98 related articles for article (PubMed ID: 15890720)
1. Hyperproduction of AmpC beta-lactamase in a clinical isolate of Escherichia coli associated with a 30 bp deletion in the attenuator region of ampC.
Fernández-Cuenca F; Pascual A; Martínez-Martínez L
J Antimicrob Chemother; 2005 Jul; 56(1):251-2. PubMed ID: 15890720
[No Abstract] [Full Text] [Related]
2. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
[TBL] [Abstract][Full Text] [Related]
3. Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR.
Tracz DM; Boyd DA; Bryden L; Hizon R; Giercke S; Van Caeseele P; Mulvey MR
J Antimicrob Chemother; 2005 May; 55(5):768-72. PubMed ID: 15761065
[TBL] [Abstract][Full Text] [Related]
4. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
[TBL] [Abstract][Full Text] [Related]
5. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
Mammeri H; Poirel L; Nordmann P
J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
[TBL] [Abstract][Full Text] [Related]
6. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
Tracz DM; Boyd DA; Hizon R; Bryce E; McGeer A; Ofner-Agostini M; Simor AE; Paton S; Mulvey MR;
FEMS Microbiol Lett; 2007 May; 270(2):265-71. PubMed ID: 17326753
[TBL] [Abstract][Full Text] [Related]
7. Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals.
Bogaerts P; Rodriguez-Villalobos H; Laurent C; Deplano A; Struelens MJ; Glupczynski Y
J Antimicrob Chemother; 2009 May; 63(5):1073-5. PubMed ID: 19240070
[No Abstract] [Full Text] [Related]
8. Comment on: extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
Sohn SG; Lee JJ; Sohn ES; Kang LW; Lee SH
J Antimicrob Chemother; 2008 Apr; 61(4):965-6; author reply 966. PubMed ID: 18227084
[No Abstract] [Full Text] [Related]
9. Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A.
Corvec S; Prodhomme A; Giraudeau C; Dauvergne S; Reynaud A; Caroff N
J Antimicrob Chemother; 2007 Oct; 60(4):872-6. PubMed ID: 17660264
[TBL] [Abstract][Full Text] [Related]
10. Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities.
Kim SH; Wei CI
J Appl Microbiol; 2007 Aug; 103(2):400-8. PubMed ID: 17650200
[TBL] [Abstract][Full Text] [Related]
11. Identification of a chromosome-borne class C beta-lactamase from Erwinia rhapontici.
Naas T; Aubert D; Vimont S; Nordmann P
J Antimicrob Chemother; 2004 Nov; 54(5):932-5. PubMed ID: 15472000
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.
Mammeri H; Eb F; Berkani A; Nordmann P
J Antimicrob Chemother; 2008 Mar; 61(3):498-503. PubMed ID: 18250231
[TBL] [Abstract][Full Text] [Related]
13. CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates.
Mocktar C; Govinden U; Sturm AW; Essack SY
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):405-8. PubMed ID: 18207348
[TBL] [Abstract][Full Text] [Related]
14. Characterization of poxB, a chromosomal-encoded Pseudomonas aeruginosa oxacillinase.
Kong KF; Jayawardena SR; Del Puerto A; Wiehlmann L; Laabs U; Tümmler B; Mathee K
Gene; 2005 Sep; 358():82-92. PubMed ID: 16120476
[TBL] [Abstract][Full Text] [Related]
15. The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli.
Netzel TC; Jindani I; Hanson N; Turner BM; Smith L; Rand KH
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):345-8. PubMed ID: 17379469
[TBL] [Abstract][Full Text] [Related]
16. MLST typing of Escherichia coli isolates overproducing AmpC {beta}-lactamase.
Guillouzouic A; Caroff N; Dauvergne S; Lepelletier D; Perrin Guyomard A; Kempf I; Reynaud A; Corvec S
J Antimicrob Chemother; 2009 Jun; 63(6):1290-2. PubMed ID: 19307170
[No Abstract] [Full Text] [Related]
17. [Genotype distribution of extended-spectrum beta-lactamases and AmpC beta-lactamases produced in Escherichia coli isolated from men with urinary infection].
Wang WP; Shao HF; Wang JN; Zhang XW; Shi LN
Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1000-3. PubMed ID: 17146926
[TBL] [Abstract][Full Text] [Related]
18. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase.
Fernández-Cuenca F; Rodríguez-Martínez JM; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2006 Jun; 27(6):549-52. PubMed ID: 16697150
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
[TBL] [Abstract][Full Text] [Related]
20. Potential evolution of hydrolysis spectrum for AmpC beta-lactamase of Escherichia coli.
Le Turnier S; Nordmann P; Eb F; Mammeri H
J Antimicrob Chemother; 2009 Jan; 63(1):216-8. PubMed ID: 18957396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
